Sting has thrived in numerous settings, but his current Sting 3.0 trio is especially potent, as they proved during a 23-song ...

Trade Show News Network (TSNN) opened nominations for its 14th annual TSNN Awards, recognizing trade show excellence and ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. A year into this devastating war, what are you feeling and thinking? How have your ...

About 74% of adult Americans are overweight or obese, and obesity leads to about $480 billion in extra medical care costs, ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

HIGHLIGHTSAt the Egina Gold Project, De Grey Mining (ASX: DEG) has continued an aggressive exploration program at the Becher ...

Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

Novo Nordisk today announced that in a phase 2a trial, monlunabant, a novel oral cannabinoid receptor 1 inverse agonist, was ...